查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087746

血栓除去裝置市場：依系統類型、器材組件、最終用戶和臨床應用分類－2026-2032年全球市場預測

Thrombectomy Devices Market by System Type, Device Component, End User, Clinical Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血栓除去裝置市場將成長至 55.2 億美元，複合年成長率為 7.81%。

主要市場統計數據
基準年 2025 32.6億美元
預計年份：2026年 35億美元
預測年份 2032 55.2億美元
複合年成長率 (%) 7.81%

血栓除去裝置市場執行摘要

血栓除去裝置在適當的患者和適當的時間使用時，在現代急性缺血性腦中風治療中發揮核心作用，因為它們可以物理性地清除主要血管閉塞並恢復腦血流。隨機試驗和總結分析的證據已證實，血管內血栓切除術是合格的循環前主要血管閉塞的標準治療方法，並且指南支持的治療窗口已延長至24小時，適用於根據高級影像學檢查篩選出的患者。

血栓切除術領域的變革性變化

血栓除去裝置的市場格局正從單一器械市場轉向整合式中風系統市場。由於從轉運到穿刺的時間以及再灌注時間直接影響後遺症的嚴重程度，醫院擴大將血栓切除平台與神經影像學、轉運流程、中風團隊部署、麻醉方案以及術後結果追蹤等因素相結合進行評估。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過加速檢測大血管閉塞、輔助灌注評估、優先處理緊急通知以及累積初級中風中心與具備取栓能力的醫院之間的轉診，對整個取栓流程產生累積性影響。許多卒中網路正在採用符合監管規定的 AI 卒中影像工具，以減少診斷延誤、規範分診流程，並幫助臨床醫生識別可能受益於血管內取栓術的患者。

主要區域洞察：亞太地區、北美地區、歐洲地區和新興地區

北美地區憑藉其成熟的卒中中心認證體系、強大的介入神經放射學能力、廣泛的電腦斷層血管造影術（CTA）和灌注成像技術，以及完善的重大血栓除去裝置卒中臨床診療方案，仍然是血栓切除器械的主要應用地區。在歐洲，由於國家和地區中風網路、基於指南的診療方案以及抽吸和血栓摘取支架技術的廣泛應用，血栓切除器械的需求依然旺盛，但其使用率因國家、醫保體系和醫院排名而異。

關鍵區域洞察：東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

在東協地區，新加坡、泰國、馬來西亞、印尼、越南和菲律賓正在投資興建中風專科醫院、進行公眾宣傳活動並改善急救轉運系統，這導致對血栓除去裝置的需求不斷成長。然而，目前這些器械的取得仍然主要集中在都市區和三級醫療機構。海灣合作理事會（GCC）國家正透過投資公共衛生、招募專家、引進先進影像設備以及進行數位化急救醫療協作，建構先進的神經血管疾病診療項目，從而支持快速識別和轉運需要取栓的患者。

各國主要血栓切除術市場的發展趨勢

美國在取栓手術​​、技術應用、臨床研究活動以及人工智慧驅動的卒中分診方面均處於世界領先地位，這得益於其完善的卒中中心網路和成熟的保險報銷體系。加拿大則專注於區域中風系統、遠距中風醫療以及覆蓋廣闊區域的協調轉運，而墨西哥和巴西則透過大都會圈醫院、公共和私人投資以及提升主要都市區專科醫生的能力來擴大治療覆蓋範圍。

為血栓除去裝置行業的領導者提供的實用建議

產業領導企業應優先考慮產生臨床證據、快速整合到工作流程以及實現差異化的器械性能。最具吸引力的策略包括：在首次介入治療中實現再灌注、降低遠端栓塞風險、改善在複雜血管中的導航、支持抽吸和血栓摘取支架聯合使用，以及確保器械與常用入路系統的兼容性。

調查方法

本執行摘要採用結構化的二級研究方法編寫，整合了基於指南的卒中治療證據、同行評審的取栓研究途徑數據、監管訊號、醫院採納趨勢以及區域醫療保健系統指標。主要證據來源包括已發表的臨床試驗、中風學會指南、公共監管資料庫、國家中風治療框架、醫院認證標準以及來自國內外公共機構的可靠醫療統計數據。

結論

血栓除去裝置市場正進入更一體化的階段，器械創新、人工智慧輔助分診、中風網路成熟度、手術訓練以及循證報銷機制等因素正在決定競爭優勢。全球缺血性中風的沉重負擔以及強力的臨床證據表明，及時進行血栓切除術能夠改善合格的大血管閉塞患者的預後，都推動了市場需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：血栓除去裝置市場：依系統類型分類

  • 超音波輔助溶栓
  • 旋轉栓塞術
  • 溶栓治療
  • 再理論栓塞
  • 抽吸血栓切除手術

第8章：血栓除去裝置市場：依器械組件分類

  • 導管
  • 訪問交付工具
  • 耗材和治療包
  • 附件和輔助設備

第9章：血栓除去裝置市場：依最終用戶分類

  • 研究和學術機構
  • 門診手術中心
  • 醫院
  • 專科診所

第10章：血栓除去裝置市場：依臨床應用分類

  • 周邊/靜脈
    • 腎/腸系膜血栓症
    • 肺動脈栓塞（PE）
    • 深層靜脈栓塞症（DVT）
  • 神經血管
    • 腦靜脈血栓症
    • 急性缺血性腦中風
  • 心血管系統
    • 周邊動脈血栓症
    • 冠狀動脈栓塞

第11章：血栓除去裝置市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：血栓除去裝置市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：血栓除去裝置市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Abbott Laboratories
  • Acandis GmbH
  • Anaconda Biomed
  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Control Medical Technology, LLC
  • Cook Group Incorporated
  • Endocor GmbH
  • Inquis Medical
  • Johnson & Johnson Services, Inc.
  • Kaneka Corporation
  • Koninklijke Philips NV
  • LeMaitre Vascular, Inc.
  • Medico's Hirata Inc.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems, Inc.
  • NeuroVasc Technologies Inc.
  • Nipro Corporation
  • Penumbra, Inc.
  • Rapid Medical, Inc.
  • Stryker Corporation
  • Surmodics, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Uniphar Medtech
  • VESALIO
  • Wallaby Medical Holding, Inc.
Product Code: MRR-030298DFFFC6

The Thrombectomy Devices Market is projected to grow by USD 5.52 billion at a CAGR of 7.81% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.26 billion
Estimated Year [2026] USD 3.50 billion
Forecast Year [2032] USD 5.52 billion
CAGR (%) 7.81%

Thrombectomy Devices Market Executive Summary

Thrombectomy devices are central to modern acute ischemic stroke care because they can physically remove large-vessel occlusions and restore cerebral blood flow when used in the right patient at the right time. Evidence from randomized trials and pooled analyses has established endovascular thrombectomy as standard of care for eligible anterior-circulation large-vessel occlusion, with guideline-supported treatment windows extending to 24 hours in selected patients based on advanced imaging.

The thrombectomy devices landscape is shaped by rising stroke burden, expanding comprehensive stroke center networks, improvements in stent retrievers and aspiration catheters, and growing use of perfusion imaging to identify salvageable brain tissue. Device manufacturers, hospitals, and health systems are competing on speed, reperfusion quality, safety, and workflow integration rather than device mechanics alone.

Transformative Shifts in the Thrombectomy Landscape

The thrombectomy devices landscape is shifting from a device-only market to an integrated stroke systems market. Hospitals increasingly evaluate thrombectomy platforms alongside neuroimaging, transfer protocols, stroke team activation, anesthesia pathways, and post-procedure outcome tracking, because door-to-puncture and reperfusion times directly influence disability outcomes.

Technology is also moving toward larger-bore aspiration systems, improved catheter trackability, combined stent retriever-aspiration techniques, and device designs that support first-pass effect. At the same time, reimbursement pressure and value-based care are pushing suppliers to demonstrate measurable improvements in workflow efficiency, recanalization performance, complication reduction, and total episode-of-care economics.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is having a cumulative effect across the thrombectomy pathway by accelerating large-vessel occlusion detection, supporting perfusion assessment, prioritizing emergency notifications, and coordinating transfers between primary stroke centers and thrombectomy-capable hospitals. Regulated AI stroke imaging tools have been adopted by many stroke networks to reduce diagnostic delays, standardize triage, and help clinicians identify patients who may benefit from endovascular thrombectomy.

AI does not replace clinical judgment, but it improves the consistency of time-critical decisions. The strongest near-term opportunity is the integration of AI alerts, imaging review, electronic health records, cath lab readiness, ambulance coordination, and outcomes registries into a single operational workflow that helps teams identify eligible patients faster and measure real-world performance more reliably.

Key Regional Insights: Asia-Pacific, North America, Europe, and Emerging Regions

North America remains a leading region for thrombectomy devices due to mature stroke center certification, strong neurointerventional capacity, broad adoption of computed tomography angiography and perfusion imaging, and established clinical pathways for large-vessel occlusion stroke. Europe shows sustained demand through national and regional stroke networks, guideline-aligned care pathways, and high use of aspiration and stent retriever technologies, although access can vary by country, reimbursement structure, and hospital tier.

Asia-Pacific is the fastest-changing opportunity area as China, India, Japan, South Korea, and Australia expand neurovascular infrastructure, improve emergency stroke triage, and increase adoption of advanced imaging in tertiary hospitals. Latin America is advancing through centers of excellence in Brazil and Mexico, but uneven reimbursement, limited specialist availability outside major cities, and inter-hospital transfer times remain barriers. The Middle East, led by high-investment health systems in Gulf countries, is expanding comprehensive stroke services, digital emergency coordination, and specialist training, while Africa remains underpenetrated due to limited neurointerventional workforce, imaging access, emergency transport coverage, and concentration of thrombectomy services in a small number of urban referral centers.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, demand for thrombectomy devices is rising as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines invest in stroke-ready hospitals, public awareness, and emergency referral systems, though access remains concentrated in urban centers and tertiary institutions. GCC countries are building advanced neurovascular programs through public health investment, specialist recruitment, high-end imaging deployment, and digital emergency care coordination, supporting faster identification and transfer of eligible thrombectomy patients.

The European Union benefits from harmonized clinical guidance, structured procurement systems, cross-border clinical collaboration, and an expanding base of certified stroke centers. BRICS countries represent large-volume clinical opportunity because of high stroke incidence, population scale, and rapid hospital modernization, but reimbursement, device affordability, and specialist availability differ widely across members. G7 markets continue to define clinical benchmarks for thrombectomy workflow, imaging selection, safety reporting, and post-market evidence, while NATO-aligned countries often benefit from emergency response modernization, cross-border training, and resilient medical supply chain planning that can support time-critical stroke intervention.

Key Country Insights Across Major Thrombectomy Markets

The United States leads in thrombectomy procedure volume, technology adoption, clinical research activity, and AI-enabled stroke triage, supported by comprehensive stroke center networks and established reimbursement mechanisms. Canada emphasizes regionalized stroke systems, telestroke, and transfer coordination across large geographies, while Mexico and Brazil are expanding access through large urban hospitals, public-private investment, and growing specialist capabilities in major metropolitan areas.

In Europe, the United Kingdom, Germany, France, Italy, and Spain have mature thrombectomy programs supported by national stroke strategies, established imaging pathways, and trained neurointerventional teams, with Germany and France particularly strong in procedural capacity and specialist infrastructure. Russia has major metropolitan capabilities but uneven regional access caused by geography and variability in hospital resources. China is scaling rapidly through hospital infrastructure expansion and national stroke center development, India is growing from a large unmet-need base with increasing tertiary hospital adoption, Japan and South Korea combine advanced imaging with high device quality expectations and aging-population stroke demand, and Australia benefits from coordinated stroke networks across major cities despite geographic distance and transfer-time challenges.

Actionable Recommendations for Thrombectomy Device Leaders

Industry leaders should prioritize clinical evidence generation, faster workflow integration, and differentiated device performance. The most defensible strategies include demonstrating first-pass reperfusion, lowering distal embolization risk, improving navigation in tortuous anatomy, supporting combined aspiration-stent retriever procedures, and ensuring device compatibility across commonly used access systems.

Commercial teams should align with hospital stroke-network goals by offering physician training, simulation, protocol support, data dashboards, and AI-compatible workflow integration. Manufacturers should also localize market access strategies, strengthen distributor education in emerging regions, support regional centers of excellence, and build post-market evidence that connects device use with functional outcomes, length of stay, complication rates, and cost efficiency.

Research Methodology

This executive summary is developed using a structured secondary research approach that synthesizes guideline-based stroke care evidence, peer-reviewed thrombectomy trial data, regulatory signals, hospital adoption patterns, and regional health system indicators. Core evidence sources include published clinical trials, stroke association guidelines, public regulatory databases, national stroke care frameworks, hospital certification criteria, and reputable health statistics from national and international authorities.

Insights are validated through triangulation across clinical, commercial, regulatory, and policy sources. The methodology emphasizes verified market drivers, technology adoption signals, regional access dynamics, care pathway maturity, and measurable workflow factors such as imaging-to-puncture speed, reperfusion quality, complication reduction, and functional outcome tracking rather than unsupported growth claims.

Conclusion

The thrombectomy devices market is entering a more integrated phase in which device innovation, AI-enabled triage, stroke network maturity, procedural training, and evidence-based reimbursement determine competitive advantage. Demand is supported by the global burden of ischemic stroke and by strong clinical evidence showing that timely thrombectomy improves outcomes in eligible large-vessel occlusion patients.

Organizations that combine high-performing thrombectomy devices with workflow tools, clinical education, and region-specific access strategies will be best positioned to improve adoption while advancing patient outcomes. The next phase of competition will reward measurable speed, safety, reperfusion quality, and real-world value across the full acute stroke care pathway.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Thrombectomy Devices Market, by System Type

  • 7.1. Ultrasound-assisted Thrombolysis
  • 7.2. Rotational Embolectomy
  • 7.3. Thrombus Fragmentation
  • 7.4. Rheolytic Embolectomy
  • 7.5. Aspiration Thrombectomy

8. Thrombectomy Devices Market, by Device Component

  • 8.1. Catheters
  • 8.2. Access & Delivery Tools
  • 8.3. Consumables & Procedure Kits
  • 8.4. Ancillary / Support Devices

9. Thrombectomy Devices Market, by End User

  • 9.1. Research & Academic Institutions
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals
  • 9.4. Specialty Clinics

10. Thrombectomy Devices Market, by Clinical Application

  • 10.1. Peripheral / Venous
    • 10.1.1. Renal / Mesenteric Thrombosis
    • 10.1.2. Pulmonary Embolism (PE)
    • 10.1.3. Deep Vein Thrombosis (DVT)
  • 10.2. Neurovascular
    • 10.2.1. Cerebral Venous Thrombosis
    • 10.2.2. Acute Ischemic Stroke
  • 10.3. Cardiovascular
    • 10.3.1. Peripheral Arterial Thrombosis
    • 10.3.2. Coronary Artery Thrombosis

11. Thrombectomy Devices Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Thrombectomy Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Thrombectomy Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Abbott Laboratories
  • 15.2. Acandis GmbH
  • 15.3. Anaconda Biomed
  • 15.4. AngioDynamics, Inc.
  • 15.5. Becton, Dickinson and Company
  • 15.6. Boston Scientific Corporation
  • 15.7. Cardinal Health, Inc.
  • 15.8. Control Medical Technology, LLC
  • 15.9. Cook Group Incorporated
  • 15.10. Endocor GmbH
  • 15.11. Inquis Medical
  • 15.12. Johnson & Johnson Services, Inc.
  • 15.13. Kaneka Corporation
  • 15.14. Koninklijke Philips N.V.
  • 15.15. LeMaitre Vascular, Inc.
  • 15.16. Medico's Hirata Inc.
  • 15.17. Medtronic plc
  • 15.18. Meril Life Sciences Pvt. Ltd.
  • 15.19. Merit Medical Systems, Inc.
  • 15.20. NeuroVasc Technologies Inc.
  • 15.21. Nipro Corporation
  • 15.22. Penumbra, Inc.
  • 15.23. Rapid Medical, Inc.
  • 15.24. Stryker Corporation
  • 15.25. Surmodics, Inc.
  • 15.26. Teleflex Incorporated
  • 15.27. Terumo Corporation
  • 15.28. Uniphar Medtech
  • 15.29. VESALIO
  • 15.30. Wallaby Medical Holding, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL THROMBECTOMY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL THROMBECTOMY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL THROMBECTOMY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL THROMBECTOMY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL THROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL THROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ULTRASOUND-ASSISTED THROMBOLYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ULTRASOUND-ASSISTED THROMBOLYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ULTRASOUND-ASSISTED THROMBOLYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ROTATIONAL EMBOLECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ROTATIONAL EMBOLECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ROTATIONAL EMBOLECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL THROMBUS FRAGMENTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL THROMBUS FRAGMENTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL THROMBUS FRAGMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RHEOLYTIC EMBOLECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RHEOLYTIC EMBOLECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RHEOLYTIC EMBOLECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ASPIRATION THROMBECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ASPIRATION THROMBECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ASPIRATION THROMBECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ACCESS & DELIVERY TOOLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ACCESS & DELIVERY TOOLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ACCESS & DELIVERY TOOLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONSUMABLES & PROCEDURE KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONSUMABLES & PROCEDURE KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONSUMABLES & PROCEDURE KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANCILLARY / SUPPORT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANCILLARY / SUPPORT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANCILLARY / SUPPORT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RESEARCH & ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RESEARCH & ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RESEARCH & ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL / VENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL / VENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL / VENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RENAL / MESENTERIC THROMBOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RENAL / MESENTERIC THROMBOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RENAL / MESENTERIC THROMBOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PULMONARY EMBOLISM (PE) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PULMONARY EMBOLISM (PE) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PULMONARY EMBOLISM (PE) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DEEP VEIN THROMBOSIS (DVT) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DEEP VEIN THROMBOSIS (DVT) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DEEP VEIN THROMBOSIS (DVT) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROVASCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROVASCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROVASCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CEREBRAL VENOUS THROMBOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CEREBRAL VENOUS THROMBOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CEREBRAL VENOUS THROMBOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ACUTE ISCHEMIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ACUTE ISCHEMIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ACUTE ISCHEMIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL ARTERIAL THROMBOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL ARTERIAL THROMBOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL ARTERIAL THROMBOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CORONARY ARTERY THROMBOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CORONARY ARTERY THROMBOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CORONARY ARTERY THROMBOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 133. GCC THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. GCC THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 136. GCC THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GCC THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. GCC THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 139. GCC THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 140. GCC THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 157. G7 THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. G7 THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 160. G7 THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. G7 THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. G7 THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 163. G7 THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 164. G7 THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 165. NATO THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. NATO THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 168. NATO THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NATO THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. NATO THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 171. NATO THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 172. NATO THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 182. CANADA THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 188. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 189. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 190. MEXICO THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 193. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 196. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 197. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 198. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 201. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 204. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 205. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 214. GERMANY THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 217. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 220. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 221. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 222. FRANCE THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 225. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 228. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 229. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 230. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 233. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 236. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 237. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 238. ITALY THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 241. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 244. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 245. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 246. SPAIN THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 249. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 252. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 253. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 262. INDIA THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 265. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 268. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 269. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 270. JAPAN THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 273. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 276. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 277. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 278. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 279. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 281. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 284. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 285. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 286. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 289. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2018-2032 (USD MILLION)
  • TABLE 292. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 293. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)